News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OncoTherapy Science, Inc. And Institute For Antibodies Conclude Licensing Agreement For Anticancer Antibody


10/19/2005 5:13:12 PM

Tokyo (JCNN) - Onco Therapy Science (OTS) announced on March 31 that the company has entered into a licensing agreement with the Institute for Antibodies (IFA), a Nagoya-based company engaged in researching and developing antigens and antibodies.

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES